[8-K] BriaCell Therapeutics Corp. Warrant Reports Material Event

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Analyzing...

07/16/2025 - 04:15 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Briacell Therapeutics Corp

NASDAQ:BCTXZ

BCTXZ Rankings

N/A Ranked by Market Cap

N/A Ranked by Dividends

BCTXZ Latest News

Jul 16, 2025

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 15, 2025

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 11, 2025

BriaCell’s Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Jul 10, 2025

BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient

BCTXZ Latest SEC Filings

Jul 15, 2025

[424B4] BriaCell Therapeutics Corp. Warrant Prospectus Filed Pursuant to Rule 424(b)(4)

Jul 10, 2025

[S-1/A] BriaCell Therapeutics Corp. Warrant Amends IPO Registration Statement

Jul 9, 2025

[S-1/A] BriaCell Therapeutics Corp. Warrant Amends IPO Registration Statement

Jul 8, 2025

[FWP] BriaCell Therapeutics Corp. Warrant Free Writing Prospectus

Jul 8, 2025

[S-1] BriaCell Therapeutics Corp. Warrant Files IPO Registration Statement

BCTXZ Stock Data

Float 2.33M

Sector Pharmaceutical Preparations

City WEST VANCOUVER